~~<i id='0E8576635D'><strike id='0E8576635D'><tt id='0E8576635D'><pre id='0E8576635D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：focus 2025-09-29 11:20:23 - browse：7845

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Pharmacists can make shortage drugs, but at what cost?

leisure time

hotspot

leisure time

knowledge

leisure time

MathieuLewis-Rolland/GettyImagesNEWORLEANS—TheannualmeetingoftheAmericanSocietyofReproductiveMedicin

WSS

Impact of Dobbs ruling felt at reproductive medicine meeting

What health policies could hitch a ride on a spending bill?

How climate

The EU Joint Clinical Assessment needs to live up to its promise

White House drug czar issues call for 'recovery

Medicare’s new pay boost for primary care is angering specialists

knowledge

leisure time

leisure time

Walensky prepares to leave CDC — and Congress — behind

STAT Summit: Michael J. Fox on progress in Parkinson's research

Medical records are filled with copy

A letter from the executive editor: STAT UnitedHealth investigation

Apple is now the first public company to be valued at $3 trillion

The EU Joint Clinical Assessment needs to live up to its promise

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Today's health inequities arise from racist U.S. history, say experts

BioMarin wins approval for gene therapy to treat hemophilia A

STAT Summit: Michael J. Fox on progress in Parkinson's research

hotspot

Beam Therapeutics to lay off 20% of its staff, re

FDA gives detailed accounting of AI

Type 2 diabetes prevention programs work at large scale: study

Eli Lilly expects to double planned employment in Boston center

FDA gives detailed accounting of AI

Pharmacists can make shortage drugs, but at what cost?

hotspot

leisure time

knowledge

leisure time